[What is being investigated and who conducts clinical research related to medicines in Argentina?].

Introduction: Clinical trials that involve medicines are performed in order to determine their effectiveness and safety. In Argentina, these studies are presented either to National Administration of Drugs, Food and Medical Technology (ANMAT) to obtain drug registration, or to the National Ministry of Health (MSAL) (to obtain the official recognition). This work was carried out to increase the knowledge about the clinical trials performed in Argentina.

[Characterization of the drug supply in Argentina].

Introduction: Knowing the characteristics of the pharmaceutical market allows obtaining sensitive information to understand the supply, demand and access of the population to medicines. In order to provide primary data regarding the marketing of drugs in Argentina, the following research was performed.

Method: This is a cross-sectional quantitative-qualitative descriptive study of the Argentine pharmaceutical market, taking into account 30 years of official information provided by the National Regulatory Agency (ANMAT).

Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates in in Argentina.

Background: Irrational use of antimicrobials (ATMs) triggers microbial resistance (AMR) which has severe consequences for human health. ATM consumption varies among countries and within each territory. These data should be known, in order to perform local policies towards AMR reduction.

Disparities in antimicrobial consumption and resistance within a country: the case of beta-lactams in Argentina.

Objective: To describe bacterial resistance and antimicrobial consumption ratio at the subnational level in Argentina during 2018, considering beta-lactams group as a case-study.

Methods: Antimicrobial consumption was expressed as defined daily doses (DDD)/1000 inhabitants. Resistance of and to beta-lactams was recorded.